Michael Osthoff
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Fehrman-Ekholm I, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci M, Huber L, Stüssi-Helbling M, Albrich W, Sendi P, Osthoff M. Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Front Immunol 2023; 14:1255292.
Oct 27, 2023Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Oct 27, 2023Front Immunol 2023; 14:1255292
Urwyler Pascal, Leimbacher Marina, Charitos Panteleimon, Moser Stephan, Fehrman-Ekholm Ingela, Trendelenburg Marten, Thoma Reto, Sumer Johannes, Camacho-Ortiz Adrián, Bacci Marcelo R, Huber Lars Chistian, Stüssi-Helbling Melina, Albrich Werner, Sendi Parham, Osthoff Michael
Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.
Schaub C, Barnsteiner S, Schönenberg L, Bloch N, Dräger S, Albrich W, Conen A, Osthoff M. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist 2022; 32:11-17.
Dec 23, 2022Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.
Dec 23, 2022J Glob Antimicrob Resist 2022; 32:11-17
Schaub Cédéric, Barnsteiner Stefanie, Schönenberg Ladina, Bloch Nando, Dräger Sarah, Albrich Werner, Conen Anna, Osthoff Michael
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
Darie A, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, Schumann D, Albrich W, Hirsch H, Brutsche M, Grize L, Tamm M, Stolz D. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022; 10:877-887.
May 23, 2022Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
May 23, 2022Lancet Respir Med 2022; 10:877-887
Darie Andrei M, Khanna Nina, Jahn Kathleen, Osthoff Michael, Bassetti Stefano, Osthoff Mirjam, Schumann Desiree M, Albrich Werner, Hirsch Hans, Brutsche Martin, Grize Leticia, Tamm Michael, Stolz Daiana
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.
Adam K, Goldenberger D, Mühlethaler K, Riat A, Zbinden R, Kronenberg A, Quiblier C, Marchetti O, Khanna N, Fankhauser H, Fleury M, Neofytos D, Osthoff M, Lamoth F, Conen A, Erard V, Boggian K, Schreiber P, Zimmerli S, Bochud P, Fungal Infection Network of Switzerland (FUNGINOS). Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey. Open Forum Infect Dis 2021; 8:ofab471.
Sep 17, 2021Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.
Sep 17, 2021Open Forum Infect Dis 2021; 8:ofab471
Adam Kai-Manuel, Goldenberger Daniel, Mühlethaler Konrad, Riat Arnaud, Zbinden Reinhard, Kronenberg Andreas, Quiblier Chantal, Marchetti Oscar, Khanna Nina, Fankhauser Hans, Fleury Mapi, Neofytos Dionysios, Osthoff Michael, Lamoth Frédéric, Conen Anna, Erard Véronique, Boggian Katia, Schreiber Peter W, Zimmerli Stefan, Bochud Pierre-Yves, Fungal Infection Network of Switzerland (FUNGINOS)
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Urwyler P, Sendi P, Albrich W, Stüssi-Helbling M, Huber L, Bacci M, Camacho-Ortiz A, Sumer J, Thoma R, Trendelenburg M, Heijnen I, Moser S, Charitos P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials 2021; 22:1.
Jan 4, 2021Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Jan 4, 2021Trials 2021; 22:1
Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael
IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma
Bibert S, Bochud P, Cavassini M, Fellay J, Osthoff M, Kaiser L, Hoffmann M, Günthard H, Furrer H, Bernasconi E, Tarr P, Taffé P, Wójtowicz A, and the Swiss HIV Cohort Study. IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS 2018
Sep 17, 2018IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma
Sep 17, 2018AIDS 2018
Bibert Stéphanie, Bochud Pierre-Yves, Cavassini Matthias, Fellay Jacques, Osthoff Michael, Kaiser Laurent, Hoffmann Matthias, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Tarr Philip E, Taffé Patrick, Wójtowicz Agnieszka, and the Swiss HIV Cohort Study
Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland
Osthoff M, Trendelenburg M, Bochud P, Khanna N, Marchetti O, Zimmerli S, Thiel S, Jørgensen C, Tissot F, Wójtowicz A. Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland. J Infect 2015; 72:377-85.
Dec 28, 2015Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland
Dec 28, 2015J Infect 2015; 72:377-85
Osthoff Michael, Trendelenburg Marten, Bochud Pierre-Yves, Khanna Nina, Marchetti Oscar, Zimmerli Stephan, Thiel Steffen, Jørgensen Clara, Tissot Frédéric, Wójtowicz Agnieszka
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients
Bibert S, Bochud P, Cavassini M, Osthoff M, Kaiser L, Hoffmann M, Günthard H, Furrer H, Bernasconi E, Manuel O, Taffé P, Wójtowicz A. The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS 2014; 28:1885-9.
Aug 24, 2014The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients
Aug 24, 2014AIDS 2014; 28:1885-9
Bibert Stéphanie, Bochud Pierre-Yves, Cavassini Matthias, Osthoff Michael, Kaiser Laurent, Hoffmann Matthias, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Manuel Oriol, Taffé Patrick, Wójtowicz Agnieszka